Protocol Summaries: GSK2402968
| GSK Study ID |
Phase | Title | Status |
|---|---|---|---|
| 114876 | phase 2 | An exploratory study to assess two doses of GSK2402968 in the treatment of ambulant boys with Duchenne muscular dystrophy (DMD) | Active not recruiting |
Quick Search